CODA BIOTHERAPEUTICS
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
CODA BIOTHERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.codabiotherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
62.67 M USD
Technology used in webpage:
Viewport Meta Google Font API Content Delivery Network Euro Typekit LocalBusiness Schema Squarespace Comcast
Current Advisors List
Board_member
2021-12-01
Board_member
2019-02-01
Current Employees Featured
Michael Narachi President & CEO @ CODA Biotherapeutics
President & CEO
Kenneth Greenberg Co-Founder @ CODA Biotherapeutics
Co-Founder
2014-04-01
Nicholas Boulis Co-Founder @ CODA Biotherapeutics
Co-Founder
Joseph Glorioso Co-Founder @ CODA Biotherapeutics
Co-Founder
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-02-05 | Attenua | Attenua acquired by CODA Biotherapeutics | N/A |
Investors List
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Venture Round - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Venture Round - CODA Biotherapeutics
Versant Ventures
Versant Ventures investment in Venture Round - CODA Biotherapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - CODA Biotherapeutics
National Institutes of Health
National Institutes of Health investment in Grant - CODA Biotherapeutics
Small Business Innovation Research
Small Business Innovation Research investment in Grant - CODA Biotherapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - CODA Biotherapeutics
Versant Ventures
Versant Ventures investment in Series A - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Series A - CODA Biotherapeutics
MPM Capital
MPM Capital investment in Series A - CODA Biotherapeutics
Official Site Inspections
http://www.codabiotherapeutics.com
- Host name: 172.67.139.188
- IP address: 172.67.139.188
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CODA Biotherapeutics"
In Tough Market, CODA Quietly Shuts Doors - BioSpace
Mar 8, 2023 As life science companies feel the burn of the current economy, one Bay Area biotech, CODA Biotherapeutics, quietly shut its doors. Google shows the company as …See details»
CODA Biotherapeutics - Crunchbase Company Profile …
When was the last funding round for CODA Biotherapeutics? CODA Biotherapeutics closed its last funding round on Dec 2, 2021 from a Venture - …See details»
What Happened To CODA Biotherapeutics & Why Did It Fail?
CODA Biotherapeutics was a biotech company focused on developing chemogenetic gene therapies for neurological diseases like focal epilepsy and chronic neuropathic pain. Founded …See details»
Coda Biotherapeutics 2025 Company Profile: Valuation, …
Coda Biotherapeutics is headquartered in South San Francisco, CA. What is the size of Coda Biotherapeutics? Coda Biotherapeutics has 32 total employees. …See details»
CODA Biotherapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CODA Biotherapeutics, Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
CODA Biotherapeutics: Revenue, Worth, Valuation & Competitors …
About CODA Biotherapeutics. CODA Biotherapeutics is a Biotech related company based in South San Francisco with an estimated revenue of $2.8M, and 18 employees. It has 10 …See details»
CODA Biotherapeutics Closes $28 Million Financing led by Pacira …
Dec 2, 2021 SOUTH SAN FRANCISCO, Calif., Dec. 2, 2021 /PRNewswire/ -- CODA Biotherapeutics, Inc. ("CODA"), a preclinical-stage biopharmaceutical company developing a …See details»
CODA Biotherapeutics - Funding, Financials, Valuation & Investors
CODA Biotherapeutics is funded by 8 investors. Pacira Pharmaceuticals and MPM Capital are the most recent investors. CODA Biotherapeutics has a post-money valuation in the range of …See details»
Coda Biotherapeutics - Craft
Coda Biotherapeutics is a biotechnology company which provides a chemogenetic platform that aims to control the activity of cells to treat a disease. The Company develops a chemogenetic …See details»
CODA Biotherapeutics Overview | SignalHire Company Profile
CODA Biotherapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology, Medical Research & …See details»
Coda Biotherapeutics - Org Chart, Teams, Culture
View Coda Biotherapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
CODA Biotherapeutics - Products, Competitors, Financials, …
CODA Biotherapeutics is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform for the treatment of intractable diseases. Its platform …See details»
CODA Biotherapeutics - Contacts, Employees, Board Members, …
Organization. CODA Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... CODA Biotherapeutics has 1 …See details»
CODA Biotherapeutics Company Overview, Contact Details
Dec 2, 2021 Mpmcapital invested into Codabiotherapeutics $28M on Dec 2nd '21. CODA Biotherapeutics — a preclinical-stage biopharmaceutical company developing a gene therapy …See details»
CODA Biotherapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for CODA Biotherapeutics. See CODA Biotherapeutics company profile and funding data. Mentioned on: FEATURED IN. Startups …See details»
CODA’s Shutdown and the State of the Market: What a LifeSci …
Mar 11, 2023 CODA Biotherapeutics, a Bay Area biotech company that was co-launched by Versant Ventures and MPM Capital in 2018, has closed down due to the tough economic …See details»
CODA Biotherapeutics Closes $28 Million Financing led by Pacira ...
Dec 2, 2021 About CODA Biotherapeutics CODA Biotherapeutics, Inc., is a preclinical-stage biopharmaceutical company developing an innovative gene therapy platform to treat …See details»
Coda Biotherapeutics | CipherBio
Explore Coda Biotherapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
CODA Biotherapeutics' Chemogenetic Gene Therapy Platform Can …
Dec 7, 2021 About CODA Biotherapeutics CODA Biotherapeutics, Inc., is a preclinical-stage biopharmaceutical company developing an innovative gene therapy platform to treat …See details»
Coda bumps up series A to $34M, lays out first 2 gene therapy …
Nov 5, 2019 Coda Biotherapeutics launched in September last year with $19 million and a mission to develop gene therapies that can be switched on and off and tuned up and down.See details»